RF ABLATION PRODUCTS FOR RENAL DENERVATION HEALTHCARE PROFESSIONALS

MEDTRONIC SYMPLICITY SPYRAL™
RENAL DENERVATION SYSTEM

Backed by three randomized, sham-controlled clinical trials and the only real-world patient registry, the Symplicity Spyral RDN system has demonstrated clinically meaningful blood pressure reductions.1-3


Indications, Safety, and Warnings

The Medtronic Symplicity Spyral multi-electrode renal denervation (RDN) catheter, part of the Symplicity Spyral RDN system, which helps reduce high blood pressure (HBP) in hypertensive patients.

RIGOROUS TESTING OF THE SYMPLICITY SPYRALTM RENAL DENERVATION SYSTEM

SEE HOW SYMPLICITY SPYRAL WORKS

Learn more about the renal denervation procedure with RF ablation.

request more information

contact us
1

Kandzari DE, Böhm M, Mahfoud F, et al. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. The Lancet. 2018 Jun 9;391(10137):2346-2355.

2

Townsend RR, Mahfoud F, Kandzari DE, et al. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL-HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. The Lancet. 2017;390;2160-2170.

3

Böhm M, Kario K, Kandzari DE, et al. Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. The Lancet 2020; Published online March 29, 2020. DOI: 10.1016/ S0140-6736(20)30554-7.

Disclaimer: This page may include information about products that may not be available in your region or country. Please consult the approved indications for use. Content on specifc Medtronic products is not intended for users in markets that do not have authorization for use.